TUDOR INVESTMENT CORP ET AL - AMAG PHARMACEUTICALS INC ownership

AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 211 filers reported holding AMAG PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.

Quarter-by-quarter ownership
TUDOR INVESTMENT CORP ET AL ownership history of AMAG PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2020$167,000
-50.4%
21,821
-60.0%
0.01%
-73.3%
Q1 2020$337,000
-9.9%
54,495
+77.3%
0.03%
+76.5%
Q4 2019$374,000
-20.1%
30,735
-24.2%
0.02%
+6.2%
Q3 2019$468,000
-21.2%
40,532
-31.8%
0.02%
-5.9%
Q2 2019$594,000
-24.1%
59,432
-2.2%
0.02%
-46.9%
Q1 2019$783,000
-12.9%
60,782
+2.7%
0.03%
+77.8%
Q4 2018$899,000
-24.5%
59,202
-0.5%
0.02%
-40.0%
Q3 2018$1,191,000
+17.7%
59,527
+14.7%
0.03%
-14.3%
Q2 2018$1,012,000
+306.4%
51,908
+320.5%
0.04%
+337.5%
Q1 2018$249,000
-50.5%
12,344
-44.6%
0.01%
-46.7%
Q1 2017$503,000
+29.0%
22,300
+99.1%
0.02%
+50.0%
Q4 2016$390,000
-95.7%
11,200
-97.0%
0.01%
-94.7%
Q2 2016$8,982,000
+34.1%
375,500
+31.2%
0.19%
+11.1%
Q1 2016$6,697,000
+966.4%
286,200
+1711.4%
0.17%
+714.3%
Q3 2015$628,000
-93.5%
15,800
-88.6%
0.02%
-92.5%
Q2 2015$9,608,000
+353.4%
139,125
+258.9%
0.28%
+313.2%
Q1 2015$2,119,000
+490.3%
38,762
+359.8%
0.07%
+466.7%
Q4 2014$359,000
-17.1%
8,431
-62.4%
0.01%
-33.3%
Q1 2014$433,000
+14.2%
22,400
+43.6%
0.02%0.0%
Q4 2013$379,00015,6000.02%
Other shareholders
AMAG PHARMACEUTICALS INC shareholders Q4 2016
NameSharesValueWeighting ↓
HealthInvest Partners AB 520,000$15,699,0007.39%
Palo Alto Investors LP 2,835,792$85,613,0004.76%
Opaleye Management Inc. 150,000$4,529,0001.89%
Engaged Capital LLC 61,425$1,854,0001.15%
IRONWOOD INVESTMENT MANAGEMENT LLC 91,400$2,759,0001.14%
Endurant Capital Management LP 111,180$3,357,0001.12%
AlphaOne Investment Services, LLC 86,817$2,621,0000.94%
ASHFORD CAPITAL MANAGEMENT INC 127,625$3,853,0000.91%
ARDSLEY ADVISORY PARTNERS LP 205,000$6,189,0000.81%
STELLIAM INVESTMENT MANAGEMENT, LP 685,000$20,680,0000.62%
View complete list of AMAG PHARMACEUTICALS INC shareholders